The HealthTech Signal
PhaseV logo

PhaseV

Causal AI technology supporting clinical trial design, execution, analysis and portfolio strategy.

phasevtrials.com

What they do

PhaseV is a causal AI clinical development technology company founded in 2023 and headquartered in Cambridge, Massachusetts. On November 3, 2026 it launched BonV, an agentic AI orchestrator that turns plain-language development questions into documented trial decision memos. PhaseV scientists and Forward Deployed Engineers work alongside sponsor teams. Raviv Pryluk, PhD, is CEO and co-founder.

Source announcement

The record

Vertical
Clinical Trials
Sub-segment
Causal AI for clinical development
Product type
Platform software
Stage
Venture-backed
Headquarters
Cambridge, Massachusetts, United States
Region
North America
Founded
2023
Total funding
Undisclosed

Also in Clinical Trials

See the Clinical Trials market map

Related on The Signal

Keep exploring